Neurovascular Devices – Market Insights – Asia Pacific

The Asia Pacific neurovascular device market will see strong growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing affordability as well as access to the neurovascular devices, and rising demand for neurovascular procedures among the expanding patient population due to the urgent and severe nature of the neurovascular disease treatment procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for neurovascular devices in Asia Pacific from 2019 through 2032.

New devices are gaining approval and entering the Asia Pacific market.

Which devices are recently launched in the Asia Pacific market? How has the market dynamics changed with these product launches?

Which devices are expected to enter the market within the forecast period?

The underpenetrated Indian and Chinese neurovascular device markets have strong growth potential.

What are the factors responsible for low penetration of neurovascular devices in India and China?

What was the impact of clinical guidelines and new government initiatives on various device segments in these countries?

What strategies are competitors using in these markets to gain revenues?

Neurovascular thrombectomy devices and neurovascular embolization devices fueled the growth of overall neurovascular device market.

How much growth is expected in these market segments in the Asia Pacific region?

How will the uptake of these devices vary across the countries covered?

Clinical data results will play an important role in driving the adoption of neurovascular devices.

Which clinical trials were recently conducted in this market?

What is the expected impact of these clinical trials on the market dynamics?

Table of contents

Neurovascular Devices - Market Insights - Asia Pacific

Mayuresh Suresh Parshiwanikar

Mayuresh Parshiwanikar is an associate healthcare research and data analyst on the Cardiovascular Medtech Insights team at Clarivate, specializing in the interventional oncology and interventional cardiology device markets. Mayuresh holds a Master’s degree in Pharmaceutical Biotechnology from National Institute of Pharmaceutical Education and Research, S.A.S. Nagar.

Contact sales Login to access report

Back to all Medtech Insights reports